Skip to content
  • About Us
  • Privacy Policy
  • Contact Us
B2B Newz

B2B Newz

Daily Industry News & Updates

  • Top Stories
  • Business
  • Technology
  • Health
  • Science
  • Toggle search form
Scientists Develop Stem Cell Model To Throw Light On Lung Cancer

Scientists Develop Stem Cell Model To Throw Light On Lung Cancer

Posted on February 16, 2019February 15, 2019 By Nicholas Miller

A small cell lung cancer model based on a stem cell has been developed by Weill Cornell Medicine scientists. This will help understand how the initiation and the progression of the disease take place. Joyce Chen and associates have made this discovery about two genes that get suppressed and mutated.

Smokers are the primary victims of the disease. It becomes immune to chemotherapy and the like after a treatment of only a few months. New treatment methods were tried without success which made the US Congress and National Cancer Institute declare the cancer as recalcitrant.

The cancer sets in from lung cells known as pulmonary neuroendocrine cells (PNEC). Research until now has not found a way to make human embryonic cells transform themselves into PNECs. A differentiation process has been enabled by inducing cells akin to pulmonary neuroendocrine cells that are found in cultured human embryonic stem cells to change into lung progenitor cells. This was achieved by blocking the signaling pathway called notch pathway.

Tumor suppressor genes RB and TP53 in almost all the small cell lung cancer patients are subjected to mutations. Chen and the team have concluded that the RB undergoes an inhibition and PNECs are formed by the lung progenitor cells. These PNECs form a group of genes that could be mistaken for genes in SCLC tumors.

TP53 was next inhibited which made PNECs to begin to express genes. The genes prompt cell growth and the decaying of cells. Mice were tested with the cultured PNECs by intravenous administration.

Tumors started forming in the animals which made the team conclude that the initiation of disease was caused by the mutations of TP53 and RB.  Member of the team, Harold Varmus, said in a report in the Journal of Experimental medicine that their research would be instrumental in determining how the development of early tumors into SCLCs. This will make it possible to test the cells for their resistance and susceptibility.

Top Stories

Post navigation

Previous Post: YouTube Won’t Promote Conspiracy Videos
Next Post: Scientists Develop Tool To Identify Recurrence Of Kidney Stones

Related Posts

New Safety Feature Introduced By TikTok In India New Safety Feature Introduced By TikTok In India Top Stories
The 2 Top Bosses Bid Adieu To Facebook—Report The 2 Top Bosses Bid Adieu To Facebook—Report Top Stories
UAE’s DP World To Open Its 1st Hyperloop In India UAE’s DP World To Open Its 1st Hyperloop In India Top Stories
Over 400 Channels Terminated By YouTube After Controversy Of Child Exploitation Over 400 Channels Terminated By YouTube After Controversy Of Child Exploitation Top Stories
Facebook To Rollout Transparency Tools in India For Electoral Ads Technology
Washington Legislators Mull Vaccine Bill As Over 50 Measles Cases Reported Washington Legislators Mull Vaccine Bill As Over 50 Measles Cases Reported Top Stories

Follow us

follow us

Recent Posts

  • Ultraviolet Overexposure can now be detected via the world’s smallest, battery-free, wearable device
  • Global Automotive Collision Repair Services Market Set to Register at CAGR 3.4% During 2020–2026
  • Concrete Block and Brick Manufacturing Market Growing Demand by Major Competitor and Strategies Analysis in 2029
  • Global Wind Turbine Operations and Maintenance Market Size Will Reach $21 Billion By 2028
  • Complementary and Alternative Medicine Market Outlook, Status, Trends 2022

Who We Are

Every day, people staying around, are looking for information to better understand their journey towards future. Recognizing the challenge of finding a trusted local source of news and information, B2B News is a trusted destination for news impacting with the precise fusion of trust, reliability, genuine information crafted in the inspiring stories and many other forms of information.

Get In Touch With us

B2B News Update
2717 Wilmarco Ave,
Baltimore, MD 21223, USA
Phone: +1 410-941-6063
Email: contact@b2bnewz.com

b2bnewsUpdate_logo

Copyright © 2022 B2B Newz.

Powered by PressBook Media WordPress theme